semaglutide fda weight loss A big win for Wegovy: drug first in history to gain approval for reducing heart risks Novo Nordisk withdraws FDA application

Theyre made with real ingredients, they taste good, and they deliver enough protein to genuinely contribute to your daily total

Is that a good thing

Semaglutide (Ozempic/Wegovy) Timeline Phase 3 trials began: 2015 (SUSTAIN program for diabetes) FDA approval (Ozempic for diabetes): December 2017 Commercial availability: Early 2018 Wegovy (obesity indication) Phase 3: 2018-2020 (STEP program) Wegovy FDA approval: June 2021 Wegovy commercial launch: September 2021, immediately went into shortage due to overwhelming demand Stable widespread availability: Mid-2023 (after Novo Nordisk scaled up manufacturing) Total time from Phase 3 start to stable availability: About 8 years for diabetes indication, 5 years for obesity indication (but with significant supply constraints)

View Protocol

But the nutrient replacement rationale is only half the story